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Seduction and Insight from Cross-National Comparisons
In this issue of the Journal (pp. 875–880), Wunsch and colleagues
provide a thought-provoking paired comparison of intensive care
services during terminal hospitalizations in theUnited States and
England (1). They demonstrate that the English are more likely
to die in a hospital than are Americans, but that far fewer ter-
minal hospitalizations in England involve the intensive care unit
(ICU). Older Americans and those with nonsurgical conditions
are particularly more likely to be provided with intensive care
during their terminal hospitalization than are their English
counterparts.
Cross-national comparisons like that ofWunschand colleagues
are among themost seductive of study designs. They seem to offer
a chance to bring rigorous data to bear on the big issues of social
justice, institutional priorities, and how we ought to organize
society.Wewant such studies to tell uswhyourhealth care systems
are in the mess that they are in, and how to fix them. Yet although
cross-national comparisons can offer important insights, even the
most rigorous one-off comparisons generally cannot deliver the
answers to our pressing questions about health care systems.
Despite analyzing over 14 million terminal hospitalizations,
Wunsch and colleagues cannot truly answer (and to their credit,
do not claim to answer) the ‘‘why’’ question. Their comparison is
cross-sectional andbetween twonations. Thismethodology limits
inference about the causes of the observed cross-national differ-
ences. It may be that their finding of stark differences in use of
intensive care reflects differences betweenAmerican andEnglish
norms surrounding patient decision making, autonomy, and
entitlement. Or it may be that, unlike in the United States,
centralized budgeting and allocation of high-dependency units in
the United Kingdom precludes filling beds simply because they
are there or turning to ICUs to monitor even low-risk conditions.
With an n of 2, Wunsch and colleagues do not hope to arbitrate
between these—and other—possibilities.
Do these concerns mean that we should not attempt cross-
national comparisons of critical care? We hesitate to draw such
a conclusion. Despite the apparent limitations imposed by an n of
2, firm answers to the ‘‘why’’ questions are possible using
comparative case studies. Indeed, important questions have been
addressed in such a context: Do democracies do better than
authoritarian regimes at protecting their citizens from death due
to malnutrition or famine (2)? What role do employers play in
determining the shape of welfare states (3)? Generating valid
causal inferences from paired case studies requires engaging with
social science methodologies that may be unfamiliar to many
readers of this journal. Carefully researched, historically
grounded case studies can be leveraged to produce compelling
results by testing each step in a proposed causal pathway (4–6).
An exploration of the evolution of critical care, taking into
account diverse national histories and healthcare ecosystems,
would help contextualize what we are learning about contempo-
rary divergences in practice (7, 8). Although we currently know
very little about the implications of differences in critical care
organization and delivery for outcomes at the patient level, these
questions are simply unanswered, not unanswerable.
Even if we understood why our national systems function
as they do, and the consequences for patient outcomes, such
knowledge might not add up to a recipe for national-level in-
terventions to improve care. Awhole range of interlinked political
and policy institutions, not just the health care system, but also the
tax system, the electoral system, the territorial organization of the
state, and the organization of the medical profession, affect the
kinds of health policies that can actually be enacted, even during
periods of seeming policy openness. Health policy in the United
States and the United Kingdom is powerfully limited by path
dependence and other forms of institutional inertia (9, 10). Hence,
the policy lessons that we might draw from a cross-national com-
parison, such as that by Wunsch and colleagues, must take into
account both the potentially limited institutional room for maneu-
ver and the opportunities for real change that do exist.
Unfortunately, policy lessons from cross-national studies can
be powerful, but they will not tell us what is ‘‘right.’’ Data alone
cannot provide the normative answer about overuse and under-
use. Our beliefs about the appropriateness of current levels of
health care expenditures, and the relative value and opportunity
cost of those expenditures, are derived from normative judg-
ments, not empirical science. Comparisons illustrate the diver-
gent consequences of past policy choices, but deciding what to do
next depends on our values and ethics.
Dr. Wunsch and colleagues are conscious of such limitations,
as well as of pedestrian challenges, such as data equivalence and
decedent bias. Navigating these hazards is worthwhile, as it opens
the possibility of interesting and important new questions. If we
believe that English andAmerican hospitals providemore or less
equivalent standards of care, thenWunsch and colleagues’ results
suggest that there is substantial room for organizational differ-
ence without sacrificing quality. Cross-national comparisons can
help us think broadly about alternative approaches to care for the
critically ill, as we learnmore about how conscientious physicians
practice quite differently in different settings.
In the context of growing health budget crises, organizational
innovation might focus on maintaining clinical excellence while
reducing the costs associated with the care of patients. Although
national health policy contextsmaybedifferent, bothEnglish and
American patients are cared for in hospitals that have foundways
of making do with limited resources. This variation can be a rich
source of hypotheses about alternative ways to organize hospital
care for the critically ill. Are there conditions with equivalent
mortality regardless of the ICU?What are the costs and benefits
of providing ICU-like services on hospital floors? We cannot as-
sume that the results of comparisons of policy innovations within
one country will generalize to another context with a different
constellation of policies. But, done properly, such comparisons
could provide a reasonable foundation for carefully conducted
interventional studies, particularly at the hospital level.
Faced with a provocative finding of cross-national difference,
the scientific community faces a choice between at least two
paths. One path leads to carefully unpacking the origins of this
difference and teaching us something generally true about how
critical care systems develop. The other path leads into the
hospitals, using observational data to imagine new ways to
organize care and generate the equipoise necessary for careful
interventional studies of such innovations. The first path helps us
Supported in part by 1K08HL091249-01 from the NIH/NHLBI.
Am J Respir Crit Care Med Vol 180. pp 799–801, 2009
Internet address: www.atsjournals.org
shapenational policy levers. The latter pathhelps us redesign care
organizations to bring change to patients. Both are necessary.
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Diagnosing Tuberculosis in Patients with HIV
Do We Know Enough?
The convergence of theHIVand tuberculosis (TB) epidemics has
complicated control of both conditions (1). With shared adverse
social factors and greatly enhanced risk for TB disease among
patients with coinfection, there have been stunning rises in TB
prevalence, drug resistance, and mortality in many of the worst-
affected areas. The high fatality of the recently reported exten-
sively drug-resistant TB (XDR-TB) series inAfrica bears witness
to this ongoing crisis (2).
Inmanydeveloping areas, patientswithTBarebeingdiagnosed
largely by sputum microscopy. Unfortunately, HIV-related TB is
often sputum smear-negative. In this issue of the Journal (pp. 903–
908), Monkongdee and colleagues evaluated the performance of
acid-fast bacilli (AFB) smears and mycobacterial cultures in
diagnosing TB among persons infected with HIV in Thailand
andVietnam, using culture-confirmed TB as the gold standard (3).
Two culturemethods, solidmedium (Lowenstein Jensen [LJ]) and
liquidmedium(MycobacteriaGrowth IndicatorTube [MGIT] and
MycoF-Lytic bottle, using BACTEC systems) (BD, Franklin
Lakes, NJ), were included. AFB smears of the first collected
sputum diagnosed only 29% of culture-positive TB cases. Adding
a second and third sputum specimen for AFB smear diagnosed
only an additional 7 and 2% of cases, respectively. The authors
infer that the minimal incremental yield of the third smear in this
study makes it not worth doing and supports WHO’s recommen-
dation to use two, rather than three, sputum smears in a person
infected with HIV who is suspected of having TB (4).
Although these findings are useful in optimizing resource use,
it is by no means the whole story. In fact, the more critical finding
of this study is that, all told, reliance on either two or even three
sputumAFB smears failed to diagnose approximately two-thirds
of patients with pulmonary TB who were infected with HIV and
who would have been diagnosed if cultures had been done.
Overlooking this killer disease in people living with HIV could
have grave implications. Unlike HIV, TB spreads by air. Smear-
negativebut culture-positive cases remain an important infectious
source (5, 6).With a delay in diagnosis, both drug-susceptible and
drug-resistant bacillary strains can spread easily among subjects
infectedwithHIV and into the general community. Emphasis has
therefore been rightly put on the diagnosis of smear-negative and
extrapulmonary TB cases among persons infected with HIV in
the revised Stop TBStrategy (7) with the incorporation of clinical
evaluation, chest radiography, empirical antibiotic trial, and
sputum culture in the diagnostic workup. The current study by
Monkongdee and colleagues thus provides much-needed evi-
dence in support of such recommendations.
As previously demonstrated, MGIT cultures had a higher
diagnostic yield thanLJ solidmedium cultures (8). In the study by
Monkongdee and colleagues, one, two, and three LJ cultures
respectively identified 48, 62, and 68% of pulmonary cases in
contrast to 71, 88, and 98% forMGIT cultures. Therefore, neither
three sputum smears, nor three LJ cultures guaranteed a 70%
case detection rate of pulmonary TB. Furthermore, enlarged
peripheral lymph nodes were found in 12% of enrolled subjects,
and 42% of lymph node aspirates were culture positive. To
diagnose smear-negative and extrapulmonary tuberculosis, the
authors therefore recommend adding broth-based cultures and
lymph node aspirate (if applicable) on top of two sputum smears.
The study by Monkongdee and colleagues does not address
the issue of drug resistance. Globally, rates of drug resistance
have risen critically, and in some areas of the world, rates of
multidrug-resistant TB (MDR-TB) and XDR-TB are shock-
ingly high (9). Although two (or three) sputum smears are
useful in diagnosing approximately one-third of cases of TB, in
areas where there is significant prevalence of drug resistance,
starting patients who were smear-diagnosed on standard TB
regimens without obtaining cultures runs a clear risk of treat-
ment failure, not only undermining the ability to achieve the
World Health Organization’s target of 85% treatment success,
but also risking the amplification of further drug resistance.
Indeed, this has contributed to the rise of higher-order re-
sistance (MDR and XDR) in some geographic settings (2).
Regular use of chest radiographs and empirical trial of
antibiotics alone, although significantly increasing the numbers
of smear-negative patients with HIV treated for TB, would not
800 AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE VOL 180 2009
